PL4262824T3 - Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego - Google Patents

Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego

Info

Publication number
PL4262824T3
PL4262824T3 PL21843776.2T PL21843776T PL4262824T3 PL 4262824 T3 PL4262824 T3 PL 4262824T3 PL 21843776 T PL21843776 T PL 21843776T PL 4262824 T3 PL4262824 T3 PL 4262824T3
Authority
PL
Poland
Prior art keywords
alginate
treatment
composition containing
component composition
gellan gum
Prior art date
Application number
PL21843776.2T
Other languages
English (en)
Inventor
Luigi Mercuri
Licia Tiberi
Original Assignee
Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT102020000031421A external-priority patent/IT202000031421A1/it
Priority claimed from IT102020000031409A external-priority patent/IT202000031409A1/it
Application filed by Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L. filed Critical Drugs Minerals And Generics Italia S.R.L. In Forma Abbreviata D.M.G. Italia S.R.L.
Publication of PL4262824T3 publication Critical patent/PL4262824T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731Carrageenans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734Alginic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL21843776.2T 2020-12-18 2021-12-20 Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego PL4262824T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102020000031421A IT202000031421A1 (it) 2020-12-18 2020-12-18 Composizione multicomponente comprendente saccarosio solfato o suoi derivati per il trattamento del reflusso gastrico
IT102020000031409A IT202000031409A1 (it) 2020-12-18 2020-12-18 Composizione multicomponente comprendente gomma gellano e suo uso per il trattamento del reflusso gastrico
PCT/IB2021/062042 WO2022130359A1 (en) 2020-12-18 2021-12-20 Multicomponent composition comprising sucrose sulfate, alginate, gellan gum for the treatment of gastric reflux

Publications (1)

Publication Number Publication Date
PL4262824T3 true PL4262824T3 (pl) 2026-03-30

Family

ID=79601529

Family Applications (2)

Application Number Title Priority Date Filing Date
PL21843776.2T PL4262824T3 (pl) 2020-12-18 2021-12-20 Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego
PL21843775.4T PL4262823T3 (pl) 2020-12-18 2021-12-20 Wieloskładnikowa kompozycja obejmująca gumę gellanową i do stosowania do leczenia refluksu żołądkowego

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL21843775.4T PL4262823T3 (pl) 2020-12-18 2021-12-20 Wieloskładnikowa kompozycja obejmująca gumę gellanową i do stosowania do leczenia refluksu żołądkowego

Country Status (8)

Country Link
EP (2) EP4262823B1 (pl)
ES (1) ES3062240T3 (pl)
HR (1) HRP20260183T1 (pl)
MA (2) MA62647B1 (pl)
PL (2) PL4262824T3 (pl)
RS (2) RS67737B1 (pl)
SM (1) SMT202600047T1 (pl)
WO (2) WO2022130358A1 (pl)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910212D0 (en) * 1999-05-05 1999-06-30 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
WO2010092468A1 (en) * 2009-02-13 2010-08-19 Carlo Ghisalberti Composition comprising alginates and d-limonene to treat gerd and dyspepsia
JP6134156B2 (ja) * 2012-02-22 2017-05-24 キユーピー株式会社 下痢防止用組成物
CN105746828A (zh) * 2015-12-29 2016-07-13 青岛海之林生物科技开发有限公司 一种褐藻胶-结冷胶软糖粉基质无糖凝胶软糖
IT201600121601A1 (it) * 2016-11-30 2018-05-30 Nekkar Lab Srl Composizione orale per il trattamento del reflusso gastroesofageo e del reflusso laringo-faringeo
IT201800002625A1 (it) * 2018-02-13 2019-08-13 Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L Composizione in forma solida per uso nel trattamento dei sintomi extra-esofagei del reflusso gastrico
US11433024B2 (en) * 2018-04-27 2022-09-06 Johnson & Johnson Consumer Inc. Liquid oral pharmaceutical dosage form

Also Published As

Publication number Publication date
MA62647B1 (fr) 2026-02-27
EP4262824C0 (en) 2025-11-12
EP4262824A1 (en) 2023-10-25
HRP20260183T1 (hr) 2026-03-27
RS67737B1 (sr) 2026-03-31
MA62648B1 (fr) 2026-02-27
SMT202600047T1 (it) 2026-03-09
WO2022130358A1 (en) 2022-06-23
EP4262823A1 (en) 2023-10-25
EP4262823B1 (en) 2025-11-26
WO2022130359A1 (en) 2022-06-23
ES3062240T3 (en) 2026-04-09
PL4262823T3 (pl) 2026-04-20
RS67798B1 (sr) 2026-03-31
EP4262823C0 (en) 2025-11-26
EP4262824B1 (en) 2025-11-12

Similar Documents

Publication Publication Date Title
IL290575A (en) Preparations and methods for the treatment of disorders related to repetitive DNA
IL272367A (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
SA521422031B1 (ar) مركبات 2 – فورميل – 3 – هيدروكسي فينيلوكسي ميثيل قادرة على تعديل الهيموجلوبين
MA55082A (fr) Compositions, procédés, et kits pour l'administration de polyribonucléotides
EP3958846A4 (en) Coated drug compositions and processes for the production thereof
EP3914651A4 (en) CARBONATE AGGREGATE COMPOSITIONS AND PROCESSES FOR THEIR PREPARATION AND USE
EA201000006A1 (ru) Способы и композиции для лечения аллергических заболеваний
NO20076413L (no) Multisykliske forbindelser og fremgangsmater for deres anvendelse
EA201291125A1 (ru) Композиции глины
CR20220656A (es) Unión de anticuerpos multiespecíficos a bcma
BRPI0906466A2 (pt) Composição para cuidado oral, e, métodos para preparar uma composição oral, e para aplicar uma quantidade eficaz da composição oral
EP3960752C0 (en) BIOPOLYMER CONCENTRATION METHOD, CRYSTALLIZATION METHOD AND NANOSTRUCTURE SUBSTRATE
IL288830A (en) Methods for purifying an antibody and its preparations
EP4375302A4 (en) COMPOSITION CONTAINING A THIOL, PHOTOCURABLE COMPOSITION AND THERMOSETTING COMPOSITION
DK1989218T3 (da) 17-phosphor-steroidderivater, der er anvendelige som progesteronreceptormodulatorer
EP4110461A4 (en) COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH
BR112022006016A2 (pt) Métodos e materiais para tratar neurotoxicidade
EP3902976A4 (en) Methods and compositions for treatment of scale
EP4006046A4 (en) NEW STEVIOL GLYCOSIDE, METHOD FOR PRODUCTION, AND SWEETENER COMPOSITION CONTAINING THEM
EP4352240A4 (en) POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS AND METHODS OF USE THEREOF
PL4262824T3 (pl) Wieloskładnikowa kompozycja zawierająca siarczan sacharozy, alginian i gumę gellanową do leczenia refluksu żołądkowego
EP3985031C0 (en) Beta glucan for the treatment of thrombocytopenia
EP4025243A4 (en) CYSTATHIONINE BETA-SYNTHASE ENZYMA THERAPY FOR THE TREATMENT OF HIGH HOMOCYSTEINE LEVELS
EP4162944A4 (en) ANTIBACTERIAL AGENT FOR BACTERIA ASSOCIATED WITH PERIODONTAL DISEASE AND BACTERIA ASSOCIATED WITH DENTAL CARIES, PERIODONTAL DISEASE PREVENTIVE TREATMENT COMPOSITION, DENTAL CARIES PREVENTIVE TREATMENT COMPOSITION, GINGIVAL IMPROVEMENT COMPOSITION, GUM IMPROVEMENT COMPOSITION, PLAQUE DEPOSIT (DENTAL PLAQUE) REMOVER COMPOSITION, DRY MOUTH IMPROVEMENT COMPOSITION, SALIVA IMPROVEMENT COMPOSITION, HALITOSIS REMOVER COMPOSITION AND CONSTIPATION IMPROVEMENT COMPOSITION
EP4212624A4 (en) FUNCTIONAL FRAGMENT FOR REPROGRAMMING, ASSEMBLY AND APPLICATION THEREOF